興科蓉醫藥：年報2024.pdf

1、2024ANNUAL REPORT 年報2Corporate Information公司資料4Financial Highlights財務摘要6Chairmans Statement主席報告8Management Discussion and Analysis管理層討論及分析25Directors and Senior Management董事及高級管理層32Report of the Directors董事會報告49Corporate Governance Report企業管治報告71Independent Auditors Report獨立核數師報告78Consolidated State

2、ment of Profit or Loss and Other Comprehensive Income綜合損益及其他全面收益表79Consolidated Statement of Financial Position綜合財務狀況表81Consolidated Statement of Changes in Equity綜合權益變動表82Consolidated Statement of Cash Flows綜合現金流量表85Notes to the Consolidated Financial Statements綜合財務報表附註178Definitions釋義Contents 目錄2S

3、inco Pharmaceuticals Holdings Limited Annual Report 2024Corporate Information公司資料BOARD OF DIRECTORSExecutive DirectorsMr.Huang Xiangbin(Chairman)Mr.Huang Zhijian(Vice Chairman)(appointed with effect from 26 March 2024)Mr.Lei ShifengNon-executive DirectorMs.Jing Huan(appointed with effect from 24 Dec

4、ember 2024)Independent Non-executive DirectorsMr.Lau Ying KitMr.Liu WenfangMr.Wang QingMr.Bai ZhizhongAUDIT COMMITTEEMr.Lau Ying Kit(Chairman)Mr.Liu WenfangMr.Wang QingMr.Bai ZhizhongREMUNERATION COMMITTEEMr.Wang Qing(Chairman)Mr.Liu WenfangMr.Bai ZhizhongMr.Lei ShifengNOMINATION COMMITTEEMr.Huang X

5、iangbin(Chairman)Mr.Liu WenfangMr.Lau Ying KitINTERNAL CONTROL AND CORPORATE GOVERNANCE COMMITTEEMr.Lau Ying Kit(Chairman)Mr.Wang QingMr.Liu WenfangMr.Bai ZhizhongMr.Lei ShifengAUTHORISED REPRESENTATIVESMr.Huang XiangbinMs.Peng Yunlu(appointed with effect from 26 March 2024)Mr.Li Kin Wai(resigned wi

6、th effect from 26 March 2024)COMPANY SECRETARIESMs.Peng YunluMr.Li Kin Wai(resigned with effect from 26 March 2024)REGISTERED OFFICEPO Box 309Ugland HouseGrand Cayman,KY1-1104Cayman Islands董事會執行董事黃祥彬先生（主席）黃智健先生（副主席）（於2024年3月26日獲委任）雷世鋒先生非執行董事敬歡女士（於2024年12月24日獲委任）獨立非執行董事劉英傑先生劉文芳先生汪晴先生白志中先生審核委員會劉英傑先生（主